Your browser doesn't support javascript.
loading
Restored Cytokine-Producing Capacities of Mucosal-associated Invariant T Cells in Pediatric Cystic Fibrosis Patients Treated with Elexacaftor/Tezacaftor/Ivacaftor.
Bardin, Emmanuelle; Dietrich, Céline; Attailia, Messaouda; Ferroni, Agnès; Jamet, Anne; Lezmi, Guillaume; Sermet-Gaudelus, Isabelle; Leite-de-Moraes, Maria.
Afiliação
  • Bardin E; Université Paris Cité, Institut National de la Santé et de la Recherche Médicale (INSERM) Unité Mixte de Recherche (UMR) 1151, Centre National de la Recherche Scientifique UMR 8253, Institut Necker Enfants Malades, Team Cystic Fibrosis and Other Epithelial Respiratory Protein Misfolding Diseases, Pa
  • Dietrich C; Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Paris, France.
  • Attailia M; INSERM, Unité 1173, Infection et Inflammation, Université Paris-Saclay, Université de Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France; and.
  • Ferroni A; Team Immunoregulation and Immunopathology and.
  • Jamet A; Team Immunoregulation and Immunopathology and.
  • Lezmi G; Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Paris, France.
  • Sermet-Gaudelus I; Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Paris, France.
  • Leite-de-Moraes M; Team Pathogenesis of Systemic Infections, Université Paris Cité, INSERM UMR 1151, CNRS UMR 8253, Institut Necker Enfants Malades, Paris, France.
Am J Respir Crit Care Med ; 210(2): 243-245, 2024 07 15.
Article em En | MEDLINE | ID: mdl-38760016

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Citocinas / Quinolonas / Fibrose Cística / Benzodioxóis / Células T Invariantes Associadas à Mucosa / Aminofenóis / Indóis Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Citocinas / Quinolonas / Fibrose Cística / Benzodioxóis / Células T Invariantes Associadas à Mucosa / Aminofenóis / Indóis Idioma: En Ano de publicação: 2024 Tipo de documento: Article